Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
about
Estimation of population-based utility weights for gastric cancer-related health states.Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer.Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers
P2860
Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cost-Effectiveness Analysis of ...... s for Advanced Gastric Cancer.
@en
Cost-Effectiveness Analysis of ...... s for Advanced Gastric Cancer.
@nl
type
label
Cost-Effectiveness Analysis of ...... s for Advanced Gastric Cancer.
@en
Cost-Effectiveness Analysis of ...... s for Advanced Gastric Cancer.
@nl
prefLabel
Cost-Effectiveness Analysis of ...... s for Advanced Gastric Cancer.
@en
Cost-Effectiveness Analysis of ...... s for Advanced Gastric Cancer.
@nl
P2093
P2860
P356
P1433
P1476
Cost-Effectiveness Analysis of ...... s for Advanced Gastric Cancer.
@en
P2093
Belinda Udeh
Jessica E Lau
Michael McNamara
Simon W Lam
P2860
P304
P356
10.1002/PHAR.1870
P407
P577
2016-11-21T00:00:00Z